FinTagging
Collection
5 items
•
Updated
Dataset Viewer
context
stringlengths 21
24.6k
| category
stringclasses 2
values | entity
stringlengths 1
12
| entity_type
stringclasses 5
values | query
stringlengths 97
3.31k
| answer
stringlengths 12
168
|
|---|---|---|---|---|---|
Subsequently, we manage our operating results through four operating segments. We have two reportable segments defined by geographic region: North America and International Developed Markets. Our remaining operating segments, consisting of WEEM and AEM, are combined and disclosed as Emerging Markets. | text | four | integerItemType | text: <entity> four </entity> <entity type> integerItemType </entity type> <context> Subsequently, we manage our operating results through four operating segments. We have two reportable segments defined by geographic region: North America and International Developed Markets. Our remaining operating segments, consisting of WEEM and AEM, are combined and disclosed as Emerging Markets. </context> | us-gaap:NumberOfOperatingSegments |
Subsequently, we manage our operating results through four operating segments. We have two reportable segments defined by geographic region: North America and International Developed Markets. Our remaining operating segments, consisting of WEEM and AEM, are combined and disclosed as Emerging Markets. | text | two | integerItemType | text: <entity> two </entity> <entity type> integerItemType </entity type> <context> Subsequently, we manage our operating results through four operating segments. We have two reportable segments defined by geographic region: North America and International Developed Markets. Our remaining operating segments, consisting of WEEM and AEM, are combined and disclosed as Emerging Markets. </context> | us-gaap:NumberOfReportableSegments |
Cash equivalents include term deposits with banks, money market funds, and all highly liquid investments with original maturities of three months or less. The fair value of cash equivalents approximates the carrying amount. Cash and cash equivalents that are legally restricted as to withdrawal or usage are classified in other current assets or other non-current assets, as applicable, on the consolidated balance sheets. At December 28, 2024, we had restricted cash of $ 31 million recorded in other current assets and restricted cash of $ 121 million recorded in other non-current assets. At December 30, 2023, we had restricted cash of $ 3 million recorded in other current assets and restricted cash of $ 1 million recorded in other non-current assets. The year-over-year increase was due to the conversion of certain assets related to the U.S. postretirement medical plan to cash. See Note 11, | text | 31 | monetaryItemType | text: <entity> 31 </entity> <entity type> monetaryItemType </entity type> <context> Cash equivalents include term deposits with banks, money market funds, and all highly liquid investments with original maturities of three months or less. The fair value of cash equivalents approximates the carrying amount. Cash and cash equivalents that are legally restricted as to withdrawal or usage are classified in other current assets or other non-current assets, as applicable, on the consolidated balance sheets. At December 28, 2024, we had restricted cash of $ 31 million recorded in other current assets and restricted cash of $ 121 million recorded in other non-current assets. At December 30, 2023, we had restricted cash of $ 3 million recorded in other current assets and restricted cash of $ 1 million recorded in other non-current assets. The year-over-year increase was due to the conversion of certain assets related to the U.S. postretirement medical plan to cash. See Note 11, </context> | us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue |
Cash equivalents include term deposits with banks, money market funds, and all highly liquid investments with original maturities of three months or less. The fair value of cash equivalents approximates the carrying amount. Cash and cash equivalents that are legally restricted as to withdrawal or usage are classified in other current assets or other non-current assets, as applicable, on the consolidated balance sheets. At December 28, 2024, we had restricted cash of $ 31 million recorded in other current assets and restricted cash of $ 121 million recorded in other non-current assets. At December 30, 2023, we had restricted cash of $ 3 million recorded in other current assets and restricted cash of $ 1 million recorded in other non-current assets. The year-over-year increase was due to the conversion of certain assets related to the U.S. postretirement medical plan to cash. See Note 11, | text | 121 | monetaryItemType | text: <entity> 121 </entity> <entity type> monetaryItemType </entity type> <context> Cash equivalents include term deposits with banks, money market funds, and all highly liquid investments with original maturities of three months or less. The fair value of cash equivalents approximates the carrying amount. Cash and cash equivalents that are legally restricted as to withdrawal or usage are classified in other current assets or other non-current assets, as applicable, on the consolidated balance sheets. At December 28, 2024, we had restricted cash of $ 31 million recorded in other current assets and restricted cash of $ 121 million recorded in other non-current assets. At December 30, 2023, we had restricted cash of $ 3 million recorded in other current assets and restricted cash of $ 1 million recorded in other non-current assets. The year-over-year increase was due to the conversion of certain assets related to the U.S. postretirement medical plan to cash. See Note 11, </context> | us-gaap:RestrictedCashAndCashEquivalentsNoncurrent |
Cash equivalents include term deposits with banks, money market funds, and all highly liquid investments with original maturities of three months or less. The fair value of cash equivalents approximates the carrying amount. Cash and cash equivalents that are legally restricted as to withdrawal or usage are classified in other current assets or other non-current assets, as applicable, on the consolidated balance sheets. At December 28, 2024, we had restricted cash of $ 31 million recorded in other current assets and restricted cash of $ 121 million recorded in other non-current assets. At December 30, 2023, we had restricted cash of $ 3 million recorded in other current assets and restricted cash of $ 1 million recorded in other non-current assets. The year-over-year increase was due to the conversion of certain assets related to the U.S. postretirement medical plan to cash. See Note 11, | text | 3 | monetaryItemType | text: <entity> 3 </entity> <entity type> monetaryItemType </entity type> <context> Cash equivalents include term deposits with banks, money market funds, and all highly liquid investments with original maturities of three months or less. The fair value of cash equivalents approximates the carrying amount. Cash and cash equivalents that are legally restricted as to withdrawal or usage are classified in other current assets or other non-current assets, as applicable, on the consolidated balance sheets. At December 28, 2024, we had restricted cash of $ 31 million recorded in other current assets and restricted cash of $ 121 million recorded in other non-current assets. At December 30, 2023, we had restricted cash of $ 3 million recorded in other current assets and restricted cash of $ 1 million recorded in other non-current assets. The year-over-year increase was due to the conversion of certain assets related to the U.S. postretirement medical plan to cash. See Note 11, </context> | us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue |
Cash equivalents include term deposits with banks, money market funds, and all highly liquid investments with original maturities of three months or less. The fair value of cash equivalents approximates the carrying amount. Cash and cash equivalents that are legally restricted as to withdrawal or usage are classified in other current assets or other non-current assets, as applicable, on the consolidated balance sheets. At December 28, 2024, we had restricted cash of $ 31 million recorded in other current assets and restricted cash of $ 121 million recorded in other non-current assets. At December 30, 2023, we had restricted cash of $ 3 million recorded in other current assets and restricted cash of $ 1 million recorded in other non-current assets. The year-over-year increase was due to the conversion of certain assets related to the U.S. postretirement medical plan to cash. See Note 11, | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> Cash equivalents include term deposits with banks, money market funds, and all highly liquid investments with original maturities of three months or less. The fair value of cash equivalents approximates the carrying amount. Cash and cash equivalents that are legally restricted as to withdrawal or usage are classified in other current assets or other non-current assets, as applicable, on the consolidated balance sheets. At December 28, 2024, we had restricted cash of $ 31 million recorded in other current assets and restricted cash of $ 121 million recorded in other non-current assets. At December 30, 2023, we had restricted cash of $ 3 million recorded in other current assets and restricted cash of $ 1 million recorded in other non-current assets. The year-over-year increase was due to the conversion of certain assets related to the U.S. postretirement medical plan to cash. See Note 11, </context> | us-gaap:RestrictedCashAndCashEquivalentsNoncurrent |
, for additional information. Total cash, cash equivalents, and restricted cash was $ 1,486 million at December 28, 2024 and $ 1,404 million at December 30, 2023. | text | 1486 | monetaryItemType | text: <entity> 1486 </entity> <entity type> monetaryItemType </entity type> <context> , for additional information. Total cash, cash equivalents, and restricted cash was $ 1,486 million at December 28, 2024 and $ 1,404 million at December 30, 2023. </context> | us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
, for additional information. Total cash, cash equivalents, and restricted cash was $ 1,486 million at December 28, 2024 and $ 1,404 million at December 30, 2023. | text | 1404 | monetaryItemType | text: <entity> 1404 </entity> <entity type> monetaryItemType </entity type> <context> , for additional information. Total cash, cash equivalents, and restricted cash was $ 1,486 million at December 28, 2024 and $ 1,404 million at December 30, 2023. </context> | us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
Advertising expenses are recorded in selling, general and administrative expenses (“SG&A”). For interim reporting purposes, we charge advertising to operations as a percentage of estimated full year sales activity and marketing costs. We then review and adjust these estimates each quarter based on actual experience and other information. Our definition of advertising expenses includes advertising production costs, in-store advertising costs, agency fees, brand promotions and events, and sponsorships, in addition to costs to obtain advertising in television, radio, print, digital, and social channels. We recorded advertising expenses of $ 1,031 million in 2024, $ 1,071 million in 2023, and $ 945 million in 2022. We also incur market research costs, which are recorded in SG&A but are excluded from advertising expenses. | text | 1031 | monetaryItemType | text: <entity> 1031 </entity> <entity type> monetaryItemType </entity type> <context> Advertising expenses are recorded in selling, general and administrative expenses (“SG&A”). For interim reporting purposes, we charge advertising to operations as a percentage of estimated full year sales activity and marketing costs. We then review and adjust these estimates each quarter based on actual experience and other information. Our definition of advertising expenses includes advertising production costs, in-store advertising costs, agency fees, brand promotions and events, and sponsorships, in addition to costs to obtain advertising in television, radio, print, digital, and social channels. We recorded advertising expenses of $ 1,031 million in 2024, $ 1,071 million in 2023, and $ 945 million in 2022. We also incur market research costs, which are recorded in SG&A but are excluded from advertising expenses. </context> | us-gaap:AdvertisingExpense |
Advertising expenses are recorded in selling, general and administrative expenses (“SG&A”). For interim reporting purposes, we charge advertising to operations as a percentage of estimated full year sales activity and marketing costs. We then review and adjust these estimates each quarter based on actual experience and other information. Our definition of advertising expenses includes advertising production costs, in-store advertising costs, agency fees, brand promotions and events, and sponsorships, in addition to costs to obtain advertising in television, radio, print, digital, and social channels. We recorded advertising expenses of $ 1,031 million in 2024, $ 1,071 million in 2023, and $ 945 million in 2022. We also incur market research costs, which are recorded in SG&A but are excluded from advertising expenses. | text | 1071 | monetaryItemType | text: <entity> 1071 </entity> <entity type> monetaryItemType </entity type> <context> Advertising expenses are recorded in selling, general and administrative expenses (“SG&A”). For interim reporting purposes, we charge advertising to operations as a percentage of estimated full year sales activity and marketing costs. We then review and adjust these estimates each quarter based on actual experience and other information. Our definition of advertising expenses includes advertising production costs, in-store advertising costs, agency fees, brand promotions and events, and sponsorships, in addition to costs to obtain advertising in television, radio, print, digital, and social channels. We recorded advertising expenses of $ 1,031 million in 2024, $ 1,071 million in 2023, and $ 945 million in 2022. We also incur market research costs, which are recorded in SG&A but are excluded from advertising expenses. </context> | us-gaap:AdvertisingExpense |
Advertising expenses are recorded in selling, general and administrative expenses (“SG&A”). For interim reporting purposes, we charge advertising to operations as a percentage of estimated full year sales activity and marketing costs. We then review and adjust these estimates each quarter based on actual experience and other information. Our definition of advertising expenses includes advertising production costs, in-store advertising costs, agency fees, brand promotions and events, and sponsorships, in addition to costs to obtain advertising in television, radio, print, digital, and social channels. We recorded advertising expenses of $ 1,031 million in 2024, $ 1,071 million in 2023, and $ 945 million in 2022. We also incur market research costs, which are recorded in SG&A but are excluded from advertising expenses. | text | 945 | monetaryItemType | text: <entity> 945 </entity> <entity type> monetaryItemType </entity type> <context> Advertising expenses are recorded in selling, general and administrative expenses (“SG&A”). For interim reporting purposes, we charge advertising to operations as a percentage of estimated full year sales activity and marketing costs. We then review and adjust these estimates each quarter based on actual experience and other information. Our definition of advertising expenses includes advertising production costs, in-store advertising costs, agency fees, brand promotions and events, and sponsorships, in addition to costs to obtain advertising in television, radio, print, digital, and social channels. We recorded advertising expenses of $ 1,031 million in 2024, $ 1,071 million in 2023, and $ 945 million in 2022. We also incur market research costs, which are recorded in SG&A but are excluded from advertising expenses. </context> | us-gaap:AdvertisingExpense |
trademarks, for a total consideration of approximately $ 3.3 billion. Of the $ 3.3 billion total consideration, approximately $ 1.6 billion was attributed to the licensing of the | text | 3.3 | monetaryItemType | text: <entity> 3.3 </entity> <entity type> monetaryItemType </entity type> <context> trademarks, for a total consideration of approximately $ 3.3 billion. Of the $ 3.3 billion total consideration, approximately $ 1.6 billion was attributed to the licensing of the </context> | us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration |
trademarks, for a total consideration of approximately $ 3.3 billion. Of the $ 3.3 billion total consideration, approximately $ 1.6 billion was attributed to the licensing of the | text | 1.6 | monetaryItemType | text: <entity> 1.6 </entity> <entity type> monetaryItemType </entity type> <context> trademarks, for a total consideration of approximately $ 3.3 billion. Of the $ 3.3 billion total consideration, approximately $ 1.6 billion was attributed to the licensing of the </context> | us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets |
brand was recognized over a period of approximately three years . We recognized license income of approximately $ 54 million in 2024 and 2023, and $ 56 million in 2022, which is recorded as a reduction to SG&A. Related to this agreement, we have recorded approximately $ 1.4 billion in long-term deferred income and $ 54 million in other current liabilities at December 28, 2024, and $ 1.4 billion in long-term deferred income and $ 55 million in other current liabilities at December 30, 2023 on the consolidated balance sheet. | text | 1.4 | monetaryItemType | text: <entity> 1.4 </entity> <entity type> monetaryItemType </entity type> <context> brand was recognized over a period of approximately three years . We recognized license income of approximately $ 54 million in 2024 and 2023, and $ 56 million in 2022, which is recorded as a reduction to SG&A. Related to this agreement, we have recorded approximately $ 1.4 billion in long-term deferred income and $ 54 million in other current liabilities at December 28, 2024, and $ 1.4 billion in long-term deferred income and $ 55 million in other current liabilities at December 30, 2023 on the consolidated balance sheet. </context> | us-gaap:DeferredIncomeNoncurrent |
brand was recognized over a period of approximately three years . We recognized license income of approximately $ 54 million in 2024 and 2023, and $ 56 million in 2022, which is recorded as a reduction to SG&A. Related to this agreement, we have recorded approximately $ 1.4 billion in long-term deferred income and $ 54 million in other current liabilities at December 28, 2024, and $ 1.4 billion in long-term deferred income and $ 55 million in other current liabilities at December 30, 2023 on the consolidated balance sheet. | text | 54 | monetaryItemType | text: <entity> 54 </entity> <entity type> monetaryItemType </entity type> <context> brand was recognized over a period of approximately three years . We recognized license income of approximately $ 54 million in 2024 and 2023, and $ 56 million in 2022, which is recorded as a reduction to SG&A. Related to this agreement, we have recorded approximately $ 1.4 billion in long-term deferred income and $ 54 million in other current liabilities at December 28, 2024, and $ 1.4 billion in long-term deferred income and $ 55 million in other current liabilities at December 30, 2023 on the consolidated balance sheet. </context> | us-gaap:OtherLiabilitiesCurrent |
brand was recognized over a period of approximately three years . We recognized license income of approximately $ 54 million in 2024 and 2023, and $ 56 million in 2022, which is recorded as a reduction to SG&A. Related to this agreement, we have recorded approximately $ 1.4 billion in long-term deferred income and $ 54 million in other current liabilities at December 28, 2024, and $ 1.4 billion in long-term deferred income and $ 55 million in other current liabilities at December 30, 2023 on the consolidated balance sheet. | text | 55 | monetaryItemType | text: <entity> 55 </entity> <entity type> monetaryItemType </entity type> <context> brand was recognized over a period of approximately three years . We recognized license income of approximately $ 54 million in 2024 and 2023, and $ 56 million in 2022, which is recorded as a reduction to SG&A. Related to this agreement, we have recorded approximately $ 1.4 billion in long-term deferred income and $ 54 million in other current liabilities at December 28, 2024, and $ 1.4 billion in long-term deferred income and $ 55 million in other current liabilities at December 30, 2023 on the consolidated balance sheet. </context> | us-gaap:OtherLiabilitiesCurrent |
We maintain 12 reporting units, eight of which comprise our goodwill balance. Our indefinite-lived intangible asset balance primarily consists of a number of individual brands. We test our reporting units and brands for impairment annually as of the first day of our third quarter, or more frequently if events or circumstances indicate it is more likely than not that the fair value of a reporting unit or brand is less than its carrying amount. Such events and circumstances could include a sustained decrease in our market capitalization, increased competition or unexpected loss of market share, increased input costs beyond projections, disposals of significant brands or components of our business, unexpected business disruptions (for example due to a natural disaster, pandemic, or loss of a customer, supplier, or other significant business relationship), unexpected significant declines in operating results, significant adverse changes in the markets in which we operate, changes in income tax rates, changes in interest rates, or changes in management strategy. We test reporting units for impairment by comparing the estimated fair value of each reporting unit with its carrying amount. We test brands for impairment by comparing the estimated fair value of each brand with its carrying amount. If the carrying amount of a reporting unit or brand exceeds its estimated fair value, we record an impairment loss based on the difference between fair value and carrying amount, in the case of reporting units, not to exceed the associated carrying amount of goodwill. | text | 12 | integerItemType | text: <entity> 12 </entity> <entity type> integerItemType </entity type> <context> We maintain 12 reporting units, eight of which comprise our goodwill balance. Our indefinite-lived intangible asset balance primarily consists of a number of individual brands. We test our reporting units and brands for impairment annually as of the first day of our third quarter, or more frequently if events or circumstances indicate it is more likely than not that the fair value of a reporting unit or brand is less than its carrying amount. Such events and circumstances could include a sustained decrease in our market capitalization, increased competition or unexpected loss of market share, increased input costs beyond projections, disposals of significant brands or components of our business, unexpected business disruptions (for example due to a natural disaster, pandemic, or loss of a customer, supplier, or other significant business relationship), unexpected significant declines in operating results, significant adverse changes in the markets in which we operate, changes in income tax rates, changes in interest rates, or changes in management strategy. We test reporting units for impairment by comparing the estimated fair value of each reporting unit with its carrying amount. We test brands for impairment by comparing the estimated fair value of each brand with its carrying amount. If the carrying amount of a reporting unit or brand exceeds its estimated fair value, we record an impairment loss based on the difference between fair value and carrying amount, in the case of reporting units, not to exceed the associated carrying amount of goodwill. </context> | us-gaap:NumberOfReportingUnits |
We maintain 12 reporting units, eight of which comprise our goodwill balance. Our indefinite-lived intangible asset balance primarily consists of a number of individual brands. We test our reporting units and brands for impairment annually as of the first day of our third quarter, or more frequently if events or circumstances indicate it is more likely than not that the fair value of a reporting unit or brand is less than its carrying amount. Such events and circumstances could include a sustained decrease in our market capitalization, increased competition or unexpected loss of market share, increased input costs beyond projections, disposals of significant brands or components of our business, unexpected business disruptions (for example due to a natural disaster, pandemic, or loss of a customer, supplier, or other significant business relationship), unexpected significant declines in operating results, significant adverse changes in the markets in which we operate, changes in income tax rates, changes in interest rates, or changes in management strategy. We test reporting units for impairment by comparing the estimated fair value of each reporting unit with its carrying amount. We test brands for impairment by comparing the estimated fair value of each brand with its carrying amount. If the carrying amount of a reporting unit or brand exceeds its estimated fair value, we record an impairment loss based on the difference between fair value and carrying amount, in the case of reporting units, not to exceed the associated carrying amount of goodwill. | text | eight | integerItemType | text: <entity> eight </entity> <entity type> integerItemType </entity type> <context> We maintain 12 reporting units, eight of which comprise our goodwill balance. Our indefinite-lived intangible asset balance primarily consists of a number of individual brands. We test our reporting units and brands for impairment annually as of the first day of our third quarter, or more frequently if events or circumstances indicate it is more likely than not that the fair value of a reporting unit or brand is less than its carrying amount. Such events and circumstances could include a sustained decrease in our market capitalization, increased competition or unexpected loss of market share, increased input costs beyond projections, disposals of significant brands or components of our business, unexpected business disruptions (for example due to a natural disaster, pandemic, or loss of a customer, supplier, or other significant business relationship), unexpected significant declines in operating results, significant adverse changes in the markets in which we operate, changes in income tax rates, changes in interest rates, or changes in management strategy. We test reporting units for impairment by comparing the estimated fair value of each reporting unit with its carrying amount. We test brands for impairment by comparing the estimated fair value of each brand with its carrying amount. If the carrying amount of a reporting unit or brand exceeds its estimated fair value, we record an impairment loss based on the difference between fair value and carrying amount, in the case of reporting units, not to exceed the associated carrying amount of goodwill. </context> | us-gaap:NumberOfReportingUnits |
The Hemmer Acquisition was accounted for under the acquisition method of accounting for business combinations. Total cash consideration related to the Hemmer Acquisition was approximately 1.3 billion Brazilian reais (approximately $ 279 million at the Hemmer Acquisition Date). A noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the acquiree’s identifiable net assets, as of the Hemmer Acquisition Date. As of the Hemmer Acquisition Date, we acquired 94 % of the outstanding shares of Hemmer. In the third quarter of 2022, we completed the redemption of the remaining outstanding shares and own 100 % of the controlling interest in Hemmer. | text | 1.3 | monetaryItemType | text: <entity> 1.3 </entity> <entity type> monetaryItemType </entity type> <context> The Hemmer Acquisition was accounted for under the acquisition method of accounting for business combinations. Total cash consideration related to the Hemmer Acquisition was approximately 1.3 billion Brazilian reais (approximately $ 279 million at the Hemmer Acquisition Date). A noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the acquiree’s identifiable net assets, as of the Hemmer Acquisition Date. As of the Hemmer Acquisition Date, we acquired 94 % of the outstanding shares of Hemmer. In the third quarter of 2022, we completed the redemption of the remaining outstanding shares and own 100 % of the controlling interest in Hemmer. </context> | us-gaap:PaymentsToAcquireBusinessesGross |
The Hemmer Acquisition was accounted for under the acquisition method of accounting for business combinations. Total cash consideration related to the Hemmer Acquisition was approximately 1.3 billion Brazilian reais (approximately $ 279 million at the Hemmer Acquisition Date). A noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the acquiree’s identifiable net assets, as of the Hemmer Acquisition Date. As of the Hemmer Acquisition Date, we acquired 94 % of the outstanding shares of Hemmer. In the third quarter of 2022, we completed the redemption of the remaining outstanding shares and own 100 % of the controlling interest in Hemmer. | text | 279 | monetaryItemType | text: <entity> 279 </entity> <entity type> monetaryItemType </entity type> <context> The Hemmer Acquisition was accounted for under the acquisition method of accounting for business combinations. Total cash consideration related to the Hemmer Acquisition was approximately 1.3 billion Brazilian reais (approximately $ 279 million at the Hemmer Acquisition Date). A noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the acquiree’s identifiable net assets, as of the Hemmer Acquisition Date. As of the Hemmer Acquisition Date, we acquired 94 % of the outstanding shares of Hemmer. In the third quarter of 2022, we completed the redemption of the remaining outstanding shares and own 100 % of the controlling interest in Hemmer. </context> | us-gaap:PaymentsToAcquireBusinessesGross |
The Hemmer Acquisition was accounted for under the acquisition method of accounting for business combinations. Total cash consideration related to the Hemmer Acquisition was approximately 1.3 billion Brazilian reais (approximately $ 279 million at the Hemmer Acquisition Date). A noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the acquiree’s identifiable net assets, as of the Hemmer Acquisition Date. As of the Hemmer Acquisition Date, we acquired 94 % of the outstanding shares of Hemmer. In the third quarter of 2022, we completed the redemption of the remaining outstanding shares and own 100 % of the controlling interest in Hemmer. | text | 94 | percentItemType | text: <entity> 94 </entity> <entity type> percentItemType </entity type> <context> The Hemmer Acquisition was accounted for under the acquisition method of accounting for business combinations. Total cash consideration related to the Hemmer Acquisition was approximately 1.3 billion Brazilian reais (approximately $ 279 million at the Hemmer Acquisition Date). A noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the acquiree’s identifiable net assets, as of the Hemmer Acquisition Date. As of the Hemmer Acquisition Date, we acquired 94 % of the outstanding shares of Hemmer. In the third quarter of 2022, we completed the redemption of the remaining outstanding shares and own 100 % of the controlling interest in Hemmer. </context> | us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired |
The Hemmer Acquisition was accounted for under the acquisition method of accounting for business combinations. Total cash consideration related to the Hemmer Acquisition was approximately 1.3 billion Brazilian reais (approximately $ 279 million at the Hemmer Acquisition Date). A noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the acquiree’s identifiable net assets, as of the Hemmer Acquisition Date. As of the Hemmer Acquisition Date, we acquired 94 % of the outstanding shares of Hemmer. In the third quarter of 2022, we completed the redemption of the remaining outstanding shares and own 100 % of the controlling interest in Hemmer. | text | 100 | percentItemType | text: <entity> 100 </entity> <entity type> percentItemType </entity type> <context> The Hemmer Acquisition was accounted for under the acquisition method of accounting for business combinations. Total cash consideration related to the Hemmer Acquisition was approximately 1.3 billion Brazilian reais (approximately $ 279 million at the Hemmer Acquisition Date). A noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the acquiree’s identifiable net assets, as of the Hemmer Acquisition Date. As of the Hemmer Acquisition Date, we acquired 94 % of the outstanding shares of Hemmer. In the third quarter of 2022, we completed the redemption of the remaining outstanding shares and own 100 % of the controlling interest in Hemmer. </context> | us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired |
The Hemmer Acquisition preliminarily resulted in $ 219 million of non-tax deductible goodwill relating principally to Hemmer’s long-term experience and large presence operating in emerging markets. This goodwill was assigned to the Latin America (“LATAM”) reporting unit within Emerging Markets. In 2022, certain insignificant measurement period adjustments were made to the initial allocation, and the final amount of goodwill was adjusted to $ 215 million. In the fourth quarter of 2022, a portion of the goodwill became tax deductible following the merger of Hemmer into our existing legal entity structure. As part of our 2024 annual impairment test, we fully impaired the goodwill related to our LATAM reporting unit, and there is no goodwill carrying value remaining as of December 28, 2024. See Note 8, | text | 219 | monetaryItemType | text: <entity> 219 </entity> <entity type> monetaryItemType </entity type> <context> The Hemmer Acquisition preliminarily resulted in $ 219 million of non-tax deductible goodwill relating principally to Hemmer’s long-term experience and large presence operating in emerging markets. This goodwill was assigned to the Latin America (“LATAM”) reporting unit within Emerging Markets. In 2022, certain insignificant measurement period adjustments were made to the initial allocation, and the final amount of goodwill was adjusted to $ 215 million. In the fourth quarter of 2022, a portion of the goodwill became tax deductible following the merger of Hemmer into our existing legal entity structure. As part of our 2024 annual impairment test, we fully impaired the goodwill related to our LATAM reporting unit, and there is no goodwill carrying value remaining as of December 28, 2024. See Note 8, </context> | us-gaap:Goodwill |
The Hemmer Acquisition preliminarily resulted in $ 219 million of non-tax deductible goodwill relating principally to Hemmer’s long-term experience and large presence operating in emerging markets. This goodwill was assigned to the Latin America (“LATAM”) reporting unit within Emerging Markets. In 2022, certain insignificant measurement period adjustments were made to the initial allocation, and the final amount of goodwill was adjusted to $ 215 million. In the fourth quarter of 2022, a portion of the goodwill became tax deductible following the merger of Hemmer into our existing legal entity structure. As part of our 2024 annual impairment test, we fully impaired the goodwill related to our LATAM reporting unit, and there is no goodwill carrying value remaining as of December 28, 2024. See Note 8, | text | 215 | monetaryItemType | text: <entity> 215 </entity> <entity type> monetaryItemType </entity type> <context> The Hemmer Acquisition preliminarily resulted in $ 219 million of non-tax deductible goodwill relating principally to Hemmer’s long-term experience and large presence operating in emerging markets. This goodwill was assigned to the Latin America (“LATAM”) reporting unit within Emerging Markets. In 2022, certain insignificant measurement period adjustments were made to the initial allocation, and the final amount of goodwill was adjusted to $ 215 million. In the fourth quarter of 2022, a portion of the goodwill became tax deductible following the merger of Hemmer into our existing legal entity structure. As part of our 2024 annual impairment test, we fully impaired the goodwill related to our LATAM reporting unit, and there is no goodwill carrying value remaining as of December 28, 2024. See Note 8, </context> | us-gaap:Goodwill |
On January 18, 2022 (the “Just Spices Acquisition Date”), we acquired 85 % of the shares of Just Spices GmbH (“Just Spices”), a German-based company focused on direct-to-consumer sales of premium spice blends, from certain third-party shareholders (the “Just Spices Acquisition”). | text | 85 | percentItemType | text: <entity> 85 </entity> <entity type> percentItemType </entity type> <context> On January 18, 2022 (the “Just Spices Acquisition Date”), we acquired 85 % of the shares of Just Spices GmbH (“Just Spices”), a German-based company focused on direct-to-consumer sales of premium spice blends, from certain third-party shareholders (the “Just Spices Acquisition”). </context> | us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired |
The Just Spices Acquisition was accounted for under the acquisition method of accounting for business combinations. Total cash consideration related to the Just Spices Acquisition was approximately 214 million euros (approximately $ 243 million at the Just Spices Acquisition Date). A noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the acquiree’s identifiable net assets, as of the Just Spices Acquisition Date. Under the terms of certain transaction agreements, Just Spices’ other equity holders each have a put option to require us to purchase the remaining equity interests beginning three years after the Just Spices Acquisition Date. If the put option is not exercised, we have a call option to acquire the remaining equity interests of Just Spices. Considering the contractual terms related to the noncontrolling interest, it is classified as redeemable noncontrolling interest on our consolidated balance sheet. | text | 214 | monetaryItemType | text: <entity> 214 </entity> <entity type> monetaryItemType </entity type> <context> The Just Spices Acquisition was accounted for under the acquisition method of accounting for business combinations. Total cash consideration related to the Just Spices Acquisition was approximately 214 million euros (approximately $ 243 million at the Just Spices Acquisition Date). A noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the acquiree’s identifiable net assets, as of the Just Spices Acquisition Date. Under the terms of certain transaction agreements, Just Spices’ other equity holders each have a put option to require us to purchase the remaining equity interests beginning three years after the Just Spices Acquisition Date. If the put option is not exercised, we have a call option to acquire the remaining equity interests of Just Spices. Considering the contractual terms related to the noncontrolling interest, it is classified as redeemable noncontrolling interest on our consolidated balance sheet. </context> | us-gaap:PaymentsToAcquireBusinessesGross |
The Just Spices Acquisition was accounted for under the acquisition method of accounting for business combinations. Total cash consideration related to the Just Spices Acquisition was approximately 214 million euros (approximately $ 243 million at the Just Spices Acquisition Date). A noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the acquiree’s identifiable net assets, as of the Just Spices Acquisition Date. Under the terms of certain transaction agreements, Just Spices’ other equity holders each have a put option to require us to purchase the remaining equity interests beginning three years after the Just Spices Acquisition Date. If the put option is not exercised, we have a call option to acquire the remaining equity interests of Just Spices. Considering the contractual terms related to the noncontrolling interest, it is classified as redeemable noncontrolling interest on our consolidated balance sheet. | text | 243 | monetaryItemType | text: <entity> 243 </entity> <entity type> monetaryItemType </entity type> <context> The Just Spices Acquisition was accounted for under the acquisition method of accounting for business combinations. Total cash consideration related to the Just Spices Acquisition was approximately 214 million euros (approximately $ 243 million at the Just Spices Acquisition Date). A noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the acquiree’s identifiable net assets, as of the Just Spices Acquisition Date. Under the terms of certain transaction agreements, Just Spices’ other equity holders each have a put option to require us to purchase the remaining equity interests beginning three years after the Just Spices Acquisition Date. If the put option is not exercised, we have a call option to acquire the remaining equity interests of Just Spices. Considering the contractual terms related to the noncontrolling interest, it is classified as redeemable noncontrolling interest on our consolidated balance sheet. </context> | us-gaap:PaymentsToAcquireBusinessesGross |
Subsequent to the Just Spices Acquisition, the redeemable noncontrolling interest is measured at the greater of the amount that would be paid if settlement occurred as of the balance sheet date based on the contractually defined redemption value and its carrying amount adjusted for the net income/(loss) attributable to the noncontrolling interest. In the third quarter of 2023, we completed the redemption of an additional 5 % of the outstanding shares. In the second quarter of 2024, we completed the redemption of the remaining outstanding shares and wholly own Just Spices as of December 28, 2024. We utilized fair values at the Just Spices Acquisition Date to allocate the total consideration exchanged to the net tangible and intangible assets acquired and liabilities assumed. The purchase price allocation for the Just Spices Acquisition was final as of the fourth quarter of 2022. | text | 5 | percentItemType | text: <entity> 5 </entity> <entity type> percentItemType </entity type> <context> Subsequent to the Just Spices Acquisition, the redeemable noncontrolling interest is measured at the greater of the amount that would be paid if settlement occurred as of the balance sheet date based on the contractually defined redemption value and its carrying amount adjusted for the net income/(loss) attributable to the noncontrolling interest. In the third quarter of 2023, we completed the redemption of an additional 5 % of the outstanding shares. In the second quarter of 2024, we completed the redemption of the remaining outstanding shares and wholly own Just Spices as of December 28, 2024. We utilized fair values at the Just Spices Acquisition Date to allocate the total consideration exchanged to the net tangible and intangible assets acquired and liabilities assumed. The purchase price allocation for the Just Spices Acquisition was final as of the fourth quarter of 2022. </context> | us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired |
The Just Spices Acquisition preliminarily resulted in $ 167 million of non-tax deductible goodwill relating principally to Just Spices’ social media presence. This goodwill was assigned to the Continental Europe reporting unit within our International Developed Markets segment. In 2022, certain insignificant measurement period adjustments were made to the initial allocation, and the final amount of goodwill was adjusted to $ 156 million. See Note 8, | text | 167 | monetaryItemType | text: <entity> 167 </entity> <entity type> monetaryItemType </entity type> <context> The Just Spices Acquisition preliminarily resulted in $ 167 million of non-tax deductible goodwill relating principally to Just Spices’ social media presence. This goodwill was assigned to the Continental Europe reporting unit within our International Developed Markets segment. In 2022, certain insignificant measurement period adjustments were made to the initial allocation, and the final amount of goodwill was adjusted to $ 156 million. See Note 8, </context> | us-gaap:Goodwill |
The Just Spices Acquisition preliminarily resulted in $ 167 million of non-tax deductible goodwill relating principally to Just Spices’ social media presence. This goodwill was assigned to the Continental Europe reporting unit within our International Developed Markets segment. In 2022, certain insignificant measurement period adjustments were made to the initial allocation, and the final amount of goodwill was adjusted to $ 156 million. See Note 8, | text | 156 | monetaryItemType | text: <entity> 156 </entity> <entity type> monetaryItemType </entity type> <context> The Just Spices Acquisition preliminarily resulted in $ 167 million of non-tax deductible goodwill relating principally to Just Spices’ social media presence. This goodwill was assigned to the Continental Europe reporting unit within our International Developed Markets segment. In 2022, certain insignificant measurement period adjustments were made to the initial allocation, and the final amount of goodwill was adjusted to $ 156 million. See Note 8, </context> | us-gaap:Goodwill |
On March 11, 2024, we closed and finalized the sale of our infant nutrition business in Russia to a third party for total cash consideration of approximately $ 25 million (the “Russia Infant Transaction”). As a result of the Russia Infant Transaction, we recognized an insignificant pre-tax gain in other expense/(income) on our condensed consolidated statement of income in the first quarter of 2024. | text | 25 | monetaryItemType | text: <entity> 25 </entity> <entity type> monetaryItemType </entity type> <context> On March 11, 2024, we closed and finalized the sale of our infant nutrition business in Russia to a third party for total cash consideration of approximately $ 25 million (the “Russia Infant Transaction”). As a result of the Russia Infant Transaction, we recognized an insignificant pre-tax gain in other expense/(income) on our condensed consolidated statement of income in the first quarter of 2024. </context> | us-gaap:ProceedsFromDivestitureOfBusinesses |
On February 5, 2024, we closed and finalized the sale of 100% of the equity interests in our Papua New Guinea subsidiary, Hugo Canning Company Limited, to a third party for total cash consideration of approximately $ 22 million, which is to be paid incrementally over two years following the transaction closing date (the “Papua New Guinea Transaction”). As a result of the Papua New Guinea Transaction, we recognized a pre-tax loss on sale of business of approximately $ 80 million in other expense/(income) on our condensed consolidated statement of income in the first quarter of 2024, of which approximately $ 41 million relates to the release of accumulated foreign currency losses. | text | 22 | monetaryItemType | text: <entity> 22 </entity> <entity type> monetaryItemType </entity type> <context> On February 5, 2024, we closed and finalized the sale of 100% of the equity interests in our Papua New Guinea subsidiary, Hugo Canning Company Limited, to a third party for total cash consideration of approximately $ 22 million, which is to be paid incrementally over two years following the transaction closing date (the “Papua New Guinea Transaction”). As a result of the Papua New Guinea Transaction, we recognized a pre-tax loss on sale of business of approximately $ 80 million in other expense/(income) on our condensed consolidated statement of income in the first quarter of 2024, of which approximately $ 41 million relates to the release of accumulated foreign currency losses. </context> | us-gaap:ProceedsFromDivestitureOfBusinesses |
On February 5, 2024, we closed and finalized the sale of 100% of the equity interests in our Papua New Guinea subsidiary, Hugo Canning Company Limited, to a third party for total cash consideration of approximately $ 22 million, which is to be paid incrementally over two years following the transaction closing date (the “Papua New Guinea Transaction”). As a result of the Papua New Guinea Transaction, we recognized a pre-tax loss on sale of business of approximately $ 80 million in other expense/(income) on our condensed consolidated statement of income in the first quarter of 2024, of which approximately $ 41 million relates to the release of accumulated foreign currency losses. | text | 80 | monetaryItemType | text: <entity> 80 </entity> <entity type> monetaryItemType </entity type> <context> On February 5, 2024, we closed and finalized the sale of 100% of the equity interests in our Papua New Guinea subsidiary, Hugo Canning Company Limited, to a third party for total cash consideration of approximately $ 22 million, which is to be paid incrementally over two years following the transaction closing date (the “Papua New Guinea Transaction”). As a result of the Papua New Guinea Transaction, we recognized a pre-tax loss on sale of business of approximately $ 80 million in other expense/(income) on our condensed consolidated statement of income in the first quarter of 2024, of which approximately $ 41 million relates to the release of accumulated foreign currency losses. </context> | us-gaap:GainLossOnSaleOfBusiness |
On February 5, 2024, we closed and finalized the sale of 100% of the equity interests in our Papua New Guinea subsidiary, Hugo Canning Company Limited, to a third party for total cash consideration of approximately $ 22 million, which is to be paid incrementally over two years following the transaction closing date (the “Papua New Guinea Transaction”). As a result of the Papua New Guinea Transaction, we recognized a pre-tax loss on sale of business of approximately $ 80 million in other expense/(income) on our condensed consolidated statement of income in the first quarter of 2024, of which approximately $ 41 million relates to the release of accumulated foreign currency losses. | text | 41 | monetaryItemType | text: <entity> 41 </entity> <entity type> monetaryItemType </entity type> <context> On February 5, 2024, we closed and finalized the sale of 100% of the equity interests in our Papua New Guinea subsidiary, Hugo Canning Company Limited, to a third party for total cash consideration of approximately $ 22 million, which is to be paid incrementally over two years following the transaction closing date (the “Papua New Guinea Transaction”). As a result of the Papua New Guinea Transaction, we recognized a pre-tax loss on sale of business of approximately $ 80 million in other expense/(income) on our condensed consolidated statement of income in the first quarter of 2024, of which approximately $ 41 million relates to the release of accumulated foreign currency losses. </context> | us-gaap:ForeignCurrencyTransactionGainLossRealized |
The Powdered Cheese Transaction closed in the fourth quarter of 2022 for total cash consideration of approximately $ 108 million. As a result of the Powered Cheese Transaction closing, we recognized a pre-tax gain on sale of business of approximately $ 26 million in other expense/(income) on our consolidated statement of income. | text | 108 | monetaryItemType | text: <entity> 108 </entity> <entity type> monetaryItemType </entity type> <context> The Powdered Cheese Transaction closed in the fourth quarter of 2022 for total cash consideration of approximately $ 108 million. As a result of the Powered Cheese Transaction closing, we recognized a pre-tax gain on sale of business of approximately $ 26 million in other expense/(income) on our consolidated statement of income. </context> | us-gaap:ProceedsFromDivestitureOfBusinesses |
The Powdered Cheese Transaction closed in the fourth quarter of 2022 for total cash consideration of approximately $ 108 million. As a result of the Powered Cheese Transaction closing, we recognized a pre-tax gain on sale of business of approximately $ 26 million in other expense/(income) on our consolidated statement of income. | text | 26 | monetaryItemType | text: <entity> 26 </entity> <entity type> monetaryItemType </entity type> <context> The Powdered Cheese Transaction closed in the fourth quarter of 2022 for total cash consideration of approximately $ 108 million. As a result of the Powered Cheese Transaction closing, we recognized a pre-tax gain on sale of business of approximately $ 26 million in other expense/(income) on our consolidated statement of income. </context> | us-gaap:GainLossOnSaleOfBusiness |
We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022. | text | 270 | integerItemType | text: <entity> 270 </entity> <entity type> integerItemType </entity type> <context> We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022. </context> | us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated |
We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022. | text | 740 | integerItemType | text: <entity> 740 </entity> <entity type> integerItemType </entity type> <context> We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022. </context> | us-gaap:RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated |
We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022. | text | 20 | monetaryItemType | text: <entity> 20 </entity> <entity type> monetaryItemType </entity type> <context> We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022. </context> | us-gaap:RestructuringAndRelatedCostIncurredCost |
We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022. | text | 21 | monetaryItemType | text: <entity> 21 </entity> <entity type> monetaryItemType </entity type> <context> We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022. </context> | us-gaap:RestructuringAndRelatedCostIncurredCost |
We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022. | text | 2 | monetaryItemType | text: <entity> 2 </entity> <entity type> monetaryItemType </entity type> <context> We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022. </context> | us-gaap:RestructuringAndRelatedCostIncurredCost |
We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022. | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022. </context> | us-gaap:RestructuringAndRelatedCostIncurredCost |
We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022. | text | 225 | monetaryItemType | text: <entity> 225 </entity> <entity type> monetaryItemType </entity type> <context> We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022. </context> | us-gaap:RestructuringAndRelatedCostIncurredCost |
We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022. | text | 74 | monetaryItemType | text: <entity> 74 </entity> <entity type> monetaryItemType </entity type> <context> We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022. </context> | us-gaap:RestructuringAndRelatedCostIncurredCost |
At December 30, 2023, property, plant and equipment, net, excluded amounts classified as held for sale. Depreciation expense was $ 696 million in 2024, $ 710 million in 2023, and $ 672 million in 2022. | text | 696 | monetaryItemType | text: <entity> 696 </entity> <entity type> monetaryItemType </entity type> <context> At December 30, 2023, property, plant and equipment, net, excluded amounts classified as held for sale. Depreciation expense was $ 696 million in 2024, $ 710 million in 2023, and $ 672 million in 2022. </context> | us-gaap:Depreciation |
At December 30, 2023, property, plant and equipment, net, excluded amounts classified as held for sale. Depreciation expense was $ 696 million in 2024, $ 710 million in 2023, and $ 672 million in 2022. | text | 710 | monetaryItemType | text: <entity> 710 </entity> <entity type> monetaryItemType </entity type> <context> At December 30, 2023, property, plant and equipment, net, excluded amounts classified as held for sale. Depreciation expense was $ 696 million in 2024, $ 710 million in 2023, and $ 672 million in 2022. </context> | us-gaap:Depreciation |
At December 30, 2023, property, plant and equipment, net, excluded amounts classified as held for sale. Depreciation expense was $ 696 million in 2024, $ 710 million in 2023, and $ 672 million in 2022. | text | 672 | monetaryItemType | text: <entity> 672 </entity> <entity type> monetaryItemType </entity type> <context> At December 30, 2023, property, plant and equipment, net, excluded amounts classified as held for sale. Depreciation expense was $ 696 million in 2024, $ 710 million in 2023, and $ 672 million in 2022. </context> | us-gaap:Depreciation |
On March 31, 2024, which was the first day of our second quarter of 2024, certain organizational changes occurred that impacted our reporting unit composition within our North America segment (the “Q2 North America reorganization”). Two of our North America reporting units — Taste, Meals, and Away From Home (“TMA”), and Fresh, Beverages, and Desserts (“FBD”) — were reorganized into the four reporting units: Taste Elevation, Ready Meals and Snacking (“TMS”), Hydration & Desserts (“HD”), Meat & Cheese (“MC”), and Away from Home & Kraft Heinz Ingredients (“AFH”). The Canada and North America Coffee (“CNAC”) and Other North America reporting units were not impacted by this reorganization. | text | Two | integerItemType | text: <entity> Two </entity> <entity type> integerItemType </entity type> <context> On March 31, 2024, which was the first day of our second quarter of 2024, certain organizational changes occurred that impacted our reporting unit composition within our North America segment (the “Q2 North America reorganization”). Two of our North America reporting units — Taste, Meals, and Away From Home (“TMA”), and Fresh, Beverages, and Desserts (“FBD”) — were reorganized into the four reporting units: Taste Elevation, Ready Meals and Snacking (“TMS”), Hydration & Desserts (“HD”), Meat & Cheese (“MC”), and Away from Home & Kraft Heinz Ingredients (“AFH”). The Canada and North America Coffee (“CNAC”) and Other North America reporting units were not impacted by this reorganization. </context> | us-gaap:NumberOfReportingUnits |
As part of our Q2 North America pre-reorganization impairment test of the TMA and FBD reporting units, we utilized the discounted cash flow method under the income approach to estimate the fair values as of March 31, 2024, for these two reporting units and concluded that the fair value of these reporting units exceeded their carrying values and no impairment was recorded. | text | two | integerItemType | text: <entity> two </entity> <entity type> integerItemType </entity type> <context> As part of our Q2 North America pre-reorganization impairment test of the TMA and FBD reporting units, we utilized the discounted cash flow method under the income approach to estimate the fair values as of March 31, 2024, for these two reporting units and concluded that the fair value of these reporting units exceeded their carrying values and no impairment was recorded. </context> | us-gaap:NumberOfReportingUnits |
We performed our Q2 North America post-reorganization impairment test as of March 31, 2024, and tested the new North America reporting units (TMS, HD, MC and AFH). We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our Q2 North America post-reorganization impairment test, we recognized a non-cash impairment loss of approximately $ 854 million in SG&A in our North America segment in the second quarter of 2024. The $ 854 million impairment loss related to our MC reporting unit, which had a goodwill carrying amount of approximately $ 2.5 billion after impairment. The impairment of our MC reporting unit was driven by the disaggregation of the former FBD reporting unit, which previously held all the net assets for the HD and MC reporting units as well as the Snacking category of TMS. The other three reporting units for which no impairment charge was required were TMS, which had a goodwill carrying amount of approximately $ 15.9 billion; HD, which had a goodwill carrying amount of approximately $ 4.3 billion; and AFH, which had a goodwill carrying amount of approximately $ 2.8 billion. | text | 2.5 | monetaryItemType | text: <entity> 2.5 </entity> <entity type> monetaryItemType </entity type> <context> We performed our Q2 North America post-reorganization impairment test as of March 31, 2024, and tested the new North America reporting units (TMS, HD, MC and AFH). We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our Q2 North America post-reorganization impairment test, we recognized a non-cash impairment loss of approximately $ 854 million in SG&A in our North America segment in the second quarter of 2024. The $ 854 million impairment loss related to our MC reporting unit, which had a goodwill carrying amount of approximately $ 2.5 billion after impairment. The impairment of our MC reporting unit was driven by the disaggregation of the former FBD reporting unit, which previously held all the net assets for the HD and MC reporting units as well as the Snacking category of TMS. The other three reporting units for which no impairment charge was required were TMS, which had a goodwill carrying amount of approximately $ 15.9 billion; HD, which had a goodwill carrying amount of approximately $ 4.3 billion; and AFH, which had a goodwill carrying amount of approximately $ 2.8 billion. </context> | us-gaap:Goodwill |
We performed our Q2 North America post-reorganization impairment test as of March 31, 2024, and tested the new North America reporting units (TMS, HD, MC and AFH). We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our Q2 North America post-reorganization impairment test, we recognized a non-cash impairment loss of approximately $ 854 million in SG&A in our North America segment in the second quarter of 2024. The $ 854 million impairment loss related to our MC reporting unit, which had a goodwill carrying amount of approximately $ 2.5 billion after impairment. The impairment of our MC reporting unit was driven by the disaggregation of the former FBD reporting unit, which previously held all the net assets for the HD and MC reporting units as well as the Snacking category of TMS. The other three reporting units for which no impairment charge was required were TMS, which had a goodwill carrying amount of approximately $ 15.9 billion; HD, which had a goodwill carrying amount of approximately $ 4.3 billion; and AFH, which had a goodwill carrying amount of approximately $ 2.8 billion. | text | 15.9 | monetaryItemType | text: <entity> 15.9 </entity> <entity type> monetaryItemType </entity type> <context> We performed our Q2 North America post-reorganization impairment test as of March 31, 2024, and tested the new North America reporting units (TMS, HD, MC and AFH). We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our Q2 North America post-reorganization impairment test, we recognized a non-cash impairment loss of approximately $ 854 million in SG&A in our North America segment in the second quarter of 2024. The $ 854 million impairment loss related to our MC reporting unit, which had a goodwill carrying amount of approximately $ 2.5 billion after impairment. The impairment of our MC reporting unit was driven by the disaggregation of the former FBD reporting unit, which previously held all the net assets for the HD and MC reporting units as well as the Snacking category of TMS. The other three reporting units for which no impairment charge was required were TMS, which had a goodwill carrying amount of approximately $ 15.9 billion; HD, which had a goodwill carrying amount of approximately $ 4.3 billion; and AFH, which had a goodwill carrying amount of approximately $ 2.8 billion. </context> | us-gaap:Goodwill |
We performed our Q2 North America post-reorganization impairment test as of March 31, 2024, and tested the new North America reporting units (TMS, HD, MC and AFH). We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our Q2 North America post-reorganization impairment test, we recognized a non-cash impairment loss of approximately $ 854 million in SG&A in our North America segment in the second quarter of 2024. The $ 854 million impairment loss related to our MC reporting unit, which had a goodwill carrying amount of approximately $ 2.5 billion after impairment. The impairment of our MC reporting unit was driven by the disaggregation of the former FBD reporting unit, which previously held all the net assets for the HD and MC reporting units as well as the Snacking category of TMS. The other three reporting units for which no impairment charge was required were TMS, which had a goodwill carrying amount of approximately $ 15.9 billion; HD, which had a goodwill carrying amount of approximately $ 4.3 billion; and AFH, which had a goodwill carrying amount of approximately $ 2.8 billion. | text | 4.3 | monetaryItemType | text: <entity> 4.3 </entity> <entity type> monetaryItemType </entity type> <context> We performed our Q2 North America post-reorganization impairment test as of March 31, 2024, and tested the new North America reporting units (TMS, HD, MC and AFH). We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our Q2 North America post-reorganization impairment test, we recognized a non-cash impairment loss of approximately $ 854 million in SG&A in our North America segment in the second quarter of 2024. The $ 854 million impairment loss related to our MC reporting unit, which had a goodwill carrying amount of approximately $ 2.5 billion after impairment. The impairment of our MC reporting unit was driven by the disaggregation of the former FBD reporting unit, which previously held all the net assets for the HD and MC reporting units as well as the Snacking category of TMS. The other three reporting units for which no impairment charge was required were TMS, which had a goodwill carrying amount of approximately $ 15.9 billion; HD, which had a goodwill carrying amount of approximately $ 4.3 billion; and AFH, which had a goodwill carrying amount of approximately $ 2.8 billion. </context> | us-gaap:Goodwill |
We performed our Q2 North America post-reorganization impairment test as of March 31, 2024, and tested the new North America reporting units (TMS, HD, MC and AFH). We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our Q2 North America post-reorganization impairment test, we recognized a non-cash impairment loss of approximately $ 854 million in SG&A in our North America segment in the second quarter of 2024. The $ 854 million impairment loss related to our MC reporting unit, which had a goodwill carrying amount of approximately $ 2.5 billion after impairment. The impairment of our MC reporting unit was driven by the disaggregation of the former FBD reporting unit, which previously held all the net assets for the HD and MC reporting units as well as the Snacking category of TMS. The other three reporting units for which no impairment charge was required were TMS, which had a goodwill carrying amount of approximately $ 15.9 billion; HD, which had a goodwill carrying amount of approximately $ 4.3 billion; and AFH, which had a goodwill carrying amount of approximately $ 2.8 billion. | text | 2.8 | monetaryItemType | text: <entity> 2.8 </entity> <entity type> monetaryItemType </entity type> <context> We performed our Q2 North America post-reorganization impairment test as of March 31, 2024, and tested the new North America reporting units (TMS, HD, MC and AFH). We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our Q2 North America post-reorganization impairment test, we recognized a non-cash impairment loss of approximately $ 854 million in SG&A in our North America segment in the second quarter of 2024. The $ 854 million impairment loss related to our MC reporting unit, which had a goodwill carrying amount of approximately $ 2.5 billion after impairment. The impairment of our MC reporting unit was driven by the disaggregation of the former FBD reporting unit, which previously held all the net assets for the HD and MC reporting units as well as the Snacking category of TMS. The other three reporting units for which no impairment charge was required were TMS, which had a goodwill carrying amount of approximately $ 15.9 billion; HD, which had a goodwill carrying amount of approximately $ 4.3 billion; and AFH, which had a goodwill carrying amount of approximately $ 2.8 billion. </context> | us-gaap:Goodwill |
We performed our 2024 annual impairment test as of June 30, 2024, which was the first day of our third quarter of 2024. We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our 2024 annual impairment test, we recognized non-cash goodwill impairment losses in SG&A of approximately $ 495 million related to our Continental Europe reporting unit within our International Developed Markets segment, $ 184 million related to our LATAM reporting unit within Emerging Markets, and $ 105 million related to our AFH reporting unit within our North America segment. The impairment of our Continental Europe reporting unit was primarily driven by a reduction of future year profitability assumptions from prior estimates in non-core categories and the | text | 495 | monetaryItemType | text: <entity> 495 </entity> <entity type> monetaryItemType </entity type> <context> We performed our 2024 annual impairment test as of June 30, 2024, which was the first day of our third quarter of 2024. We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our 2024 annual impairment test, we recognized non-cash goodwill impairment losses in SG&A of approximately $ 495 million related to our Continental Europe reporting unit within our International Developed Markets segment, $ 184 million related to our LATAM reporting unit within Emerging Markets, and $ 105 million related to our AFH reporting unit within our North America segment. The impairment of our Continental Europe reporting unit was primarily driven by a reduction of future year profitability assumptions from prior estimates in non-core categories and the </context> | us-gaap:GoodwillImpairmentLoss |
We performed our 2024 annual impairment test as of June 30, 2024, which was the first day of our third quarter of 2024. We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our 2024 annual impairment test, we recognized non-cash goodwill impairment losses in SG&A of approximately $ 495 million related to our Continental Europe reporting unit within our International Developed Markets segment, $ 184 million related to our LATAM reporting unit within Emerging Markets, and $ 105 million related to our AFH reporting unit within our North America segment. The impairment of our Continental Europe reporting unit was primarily driven by a reduction of future year profitability assumptions from prior estimates in non-core categories and the | text | 184 | monetaryItemType | text: <entity> 184 </entity> <entity type> monetaryItemType </entity type> <context> We performed our 2024 annual impairment test as of June 30, 2024, which was the first day of our third quarter of 2024. We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our 2024 annual impairment test, we recognized non-cash goodwill impairment losses in SG&A of approximately $ 495 million related to our Continental Europe reporting unit within our International Developed Markets segment, $ 184 million related to our LATAM reporting unit within Emerging Markets, and $ 105 million related to our AFH reporting unit within our North America segment. The impairment of our Continental Europe reporting unit was primarily driven by a reduction of future year profitability assumptions from prior estimates in non-core categories and the </context> | us-gaap:GoodwillImpairmentLoss |
We performed our 2024 annual impairment test as of June 30, 2024, which was the first day of our third quarter of 2024. We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our 2024 annual impairment test, we recognized non-cash goodwill impairment losses in SG&A of approximately $ 495 million related to our Continental Europe reporting unit within our International Developed Markets segment, $ 184 million related to our LATAM reporting unit within Emerging Markets, and $ 105 million related to our AFH reporting unit within our North America segment. The impairment of our Continental Europe reporting unit was primarily driven by a reduction of future year profitability assumptions from prior estimates in non-core categories and the | text | 105 | monetaryItemType | text: <entity> 105 </entity> <entity type> monetaryItemType </entity type> <context> We performed our 2024 annual impairment test as of June 30, 2024, which was the first day of our third quarter of 2024. We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our 2024 annual impairment test, we recognized non-cash goodwill impairment losses in SG&A of approximately $ 495 million related to our Continental Europe reporting unit within our International Developed Markets segment, $ 184 million related to our LATAM reporting unit within Emerging Markets, and $ 105 million related to our AFH reporting unit within our North America segment. The impairment of our Continental Europe reporting unit was primarily driven by a reduction of future year profitability assumptions from prior estimates in non-core categories and the </context> | us-gaap:GoodwillImpairmentLoss |
business, as well as higher intercompany royalty expenses resulting from a change in our product mix. The impairment of our LATAM reporting unit was primarily driven by a reduction of future year profitability assumptions from prior estimates and negative macroeconomic factors, including weakening of the foreign currency exchange rate of the Brazilian real relative to the U.S. dollar. After these impairments, the goodwill carrying amount was approximately $ 2.7 billion in our AFH reporting unit, approximately $ 485 million in our Continental Europe reporting unit, and there is no goodwill carrying value remaining in our LATAM reporting unit. | text | 2.7 | monetaryItemType | text: <entity> 2.7 </entity> <entity type> monetaryItemType </entity type> <context> business, as well as higher intercompany royalty expenses resulting from a change in our product mix. The impairment of our LATAM reporting unit was primarily driven by a reduction of future year profitability assumptions from prior estimates and negative macroeconomic factors, including weakening of the foreign currency exchange rate of the Brazilian real relative to the U.S. dollar. After these impairments, the goodwill carrying amount was approximately $ 2.7 billion in our AFH reporting unit, approximately $ 485 million in our Continental Europe reporting unit, and there is no goodwill carrying value remaining in our LATAM reporting unit. </context> | us-gaap:Goodwill |
business, as well as higher intercompany royalty expenses resulting from a change in our product mix. The impairment of our LATAM reporting unit was primarily driven by a reduction of future year profitability assumptions from prior estimates and negative macroeconomic factors, including weakening of the foreign currency exchange rate of the Brazilian real relative to the U.S. dollar. After these impairments, the goodwill carrying amount was approximately $ 2.7 billion in our AFH reporting unit, approximately $ 485 million in our Continental Europe reporting unit, and there is no goodwill carrying value remaining in our LATAM reporting unit. | text | 485 | monetaryItemType | text: <entity> 485 </entity> <entity type> monetaryItemType </entity type> <context> business, as well as higher intercompany royalty expenses resulting from a change in our product mix. The impairment of our LATAM reporting unit was primarily driven by a reduction of future year profitability assumptions from prior estimates and negative macroeconomic factors, including weakening of the foreign currency exchange rate of the Brazilian real relative to the U.S. dollar. After these impairments, the goodwill carrying amount was approximately $ 2.7 billion in our AFH reporting unit, approximately $ 485 million in our Continental Europe reporting unit, and there is no goodwill carrying value remaining in our LATAM reporting unit. </context> | us-gaap:Goodwill |
As of our 2024 annual impairment test, our reporting units with 20 % or less fair value over carrying amount had an aggregate goodwill carrying amount of $ 24.1 billion and included TMS, AFH, MC, Northern Europe, CNAC, and Continental Europe. Our HD and Asia reporting units had 20 - 50 % fair value over carrying amount with an aggregate goodwill carrying amount of $ 4.6 billion as of our 2024 annual impairment test date. | text | 20 | percentItemType | text: <entity> 20 </entity> <entity type> percentItemType </entity type> <context> As of our 2024 annual impairment test, our reporting units with 20 % or less fair value over carrying amount had an aggregate goodwill carrying amount of $ 24.1 billion and included TMS, AFH, MC, Northern Europe, CNAC, and Continental Europe. Our HD and Asia reporting units had 20 - 50 % fair value over carrying amount with an aggregate goodwill carrying amount of $ 4.6 billion as of our 2024 annual impairment test date. </context> | us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount |
As of our 2024 annual impairment test, our reporting units with 20 % or less fair value over carrying amount had an aggregate goodwill carrying amount of $ 24.1 billion and included TMS, AFH, MC, Northern Europe, CNAC, and Continental Europe. Our HD and Asia reporting units had 20 - 50 % fair value over carrying amount with an aggregate goodwill carrying amount of $ 4.6 billion as of our 2024 annual impairment test date. | text | 24.1 | monetaryItemType | text: <entity> 24.1 </entity> <entity type> monetaryItemType </entity type> <context> As of our 2024 annual impairment test, our reporting units with 20 % or less fair value over carrying amount had an aggregate goodwill carrying amount of $ 24.1 billion and included TMS, AFH, MC, Northern Europe, CNAC, and Continental Europe. Our HD and Asia reporting units had 20 - 50 % fair value over carrying amount with an aggregate goodwill carrying amount of $ 4.6 billion as of our 2024 annual impairment test date. </context> | us-gaap:Goodwill |
As of our 2024 annual impairment test, our reporting units with 20 % or less fair value over carrying amount had an aggregate goodwill carrying amount of $ 24.1 billion and included TMS, AFH, MC, Northern Europe, CNAC, and Continental Europe. Our HD and Asia reporting units had 20 - 50 % fair value over carrying amount with an aggregate goodwill carrying amount of $ 4.6 billion as of our 2024 annual impairment test date. | text | 50 | percentItemType | text: <entity> 50 </entity> <entity type> percentItemType </entity type> <context> As of our 2024 annual impairment test, our reporting units with 20 % or less fair value over carrying amount had an aggregate goodwill carrying amount of $ 24.1 billion and included TMS, AFH, MC, Northern Europe, CNAC, and Continental Europe. Our HD and Asia reporting units had 20 - 50 % fair value over carrying amount with an aggregate goodwill carrying amount of $ 4.6 billion as of our 2024 annual impairment test date. </context> | us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount |
As of our 2024 annual impairment test, our reporting units with 20 % or less fair value over carrying amount had an aggregate goodwill carrying amount of $ 24.1 billion and included TMS, AFH, MC, Northern Europe, CNAC, and Continental Europe. Our HD and Asia reporting units had 20 - 50 % fair value over carrying amount with an aggregate goodwill carrying amount of $ 4.6 billion as of our 2024 annual impairment test date. | text | 4.6 | monetaryItemType | text: <entity> 4.6 </entity> <entity type> monetaryItemType </entity type> <context> As of our 2024 annual impairment test, our reporting units with 20 % or less fair value over carrying amount had an aggregate goodwill carrying amount of $ 24.1 billion and included TMS, AFH, MC, Northern Europe, CNAC, and Continental Europe. Our HD and Asia reporting units had 20 - 50 % fair value over carrying amount with an aggregate goodwill carrying amount of $ 4.6 billion as of our 2024 annual impairment test date. </context> | us-gaap:Goodwill |
As of December 28, 2024, we maintain 12 reporting units, eight of which comprise our goodwill balance. These eight reporting units had an aggregate goodwill carrying amount of $ 28.7 billion at December 28, 2024. Accumulated impairment losses to goodwill were $ 13.5 billion as of December 28, 2024 and $ 11.8 billion at December 30, 2023. | text | 12 | integerItemType | text: <entity> 12 </entity> <entity type> integerItemType </entity type> <context> As of December 28, 2024, we maintain 12 reporting units, eight of which comprise our goodwill balance. These eight reporting units had an aggregate goodwill carrying amount of $ 28.7 billion at December 28, 2024. Accumulated impairment losses to goodwill were $ 13.5 billion as of December 28, 2024 and $ 11.8 billion at December 30, 2023. </context> | us-gaap:NumberOfReportingUnits |
As of December 28, 2024, we maintain 12 reporting units, eight of which comprise our goodwill balance. These eight reporting units had an aggregate goodwill carrying amount of $ 28.7 billion at December 28, 2024. Accumulated impairment losses to goodwill were $ 13.5 billion as of December 28, 2024 and $ 11.8 billion at December 30, 2023. | text | eight | integerItemType | text: <entity> eight </entity> <entity type> integerItemType </entity type> <context> As of December 28, 2024, we maintain 12 reporting units, eight of which comprise our goodwill balance. These eight reporting units had an aggregate goodwill carrying amount of $ 28.7 billion at December 28, 2024. Accumulated impairment losses to goodwill were $ 13.5 billion as of December 28, 2024 and $ 11.8 billion at December 30, 2023. </context> | us-gaap:NumberOfReportingUnits |
As of December 28, 2024, we maintain 12 reporting units, eight of which comprise our goodwill balance. These eight reporting units had an aggregate goodwill carrying amount of $ 28.7 billion at December 28, 2024. Accumulated impairment losses to goodwill were $ 13.5 billion as of December 28, 2024 and $ 11.8 billion at December 30, 2023. | text | 28.7 | monetaryItemType | text: <entity> 28.7 </entity> <entity type> monetaryItemType </entity type> <context> As of December 28, 2024, we maintain 12 reporting units, eight of which comprise our goodwill balance. These eight reporting units had an aggregate goodwill carrying amount of $ 28.7 billion at December 28, 2024. Accumulated impairment losses to goodwill were $ 13.5 billion as of December 28, 2024 and $ 11.8 billion at December 30, 2023. </context> | us-gaap:Goodwill |
As of December 28, 2024, we maintain 12 reporting units, eight of which comprise our goodwill balance. These eight reporting units had an aggregate goodwill carrying amount of $ 28.7 billion at December 28, 2024. Accumulated impairment losses to goodwill were $ 13.5 billion as of December 28, 2024 and $ 11.8 billion at December 30, 2023. | text | 13.5 | monetaryItemType | text: <entity> 13.5 </entity> <entity type> monetaryItemType </entity type> <context> As of December 28, 2024, we maintain 12 reporting units, eight of which comprise our goodwill balance. These eight reporting units had an aggregate goodwill carrying amount of $ 28.7 billion at December 28, 2024. Accumulated impairment losses to goodwill were $ 13.5 billion as of December 28, 2024 and $ 11.8 billion at December 30, 2023. </context> | us-gaap:GoodwillImpairedAccumulatedImpairmentLoss |
As of December 28, 2024, we maintain 12 reporting units, eight of which comprise our goodwill balance. These eight reporting units had an aggregate goodwill carrying amount of $ 28.7 billion at December 28, 2024. Accumulated impairment losses to goodwill were $ 13.5 billion as of December 28, 2024 and $ 11.8 billion at December 30, 2023. | text | 11.8 | monetaryItemType | text: <entity> 11.8 </entity> <entity type> monetaryItemType </entity type> <context> As of December 28, 2024, we maintain 12 reporting units, eight of which comprise our goodwill balance. These eight reporting units had an aggregate goodwill carrying amount of $ 28.7 billion at December 28, 2024. Accumulated impairment losses to goodwill were $ 13.5 billion as of December 28, 2024 and $ 11.8 billion at December 30, 2023. </context> | us-gaap:GoodwillImpairedAccumulatedImpairmentLoss |
We performed our 2023 annual impairment test as of July 2, 2023, which was the first day of our third quarter of 2023. In performing this test, we incorporated information that was known through the date of filing of our Quarterly Report on Form 10-Q for the period ended September 30, 2023. We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our 2023 annual impairment test, we recognized a non-cash goodwill impairment loss of approximately $ 510 million in SG&A, which included a $ 452 million impairment loss in our Canada and North America Coffee (“CNAC”) reporting unit within our North America segment and a $ 58 million impairment loss in our Continental Europe reporting unit within our International Developed Markets segment. These impairments were primarily driven by an increase in the discount rate, which was impacted by higher interest rates, a decline in market capitalization, and other market inputs. | text | 452 | monetaryItemType | text: <entity> 452 </entity> <entity type> monetaryItemType </entity type> <context> We performed our 2023 annual impairment test as of July 2, 2023, which was the first day of our third quarter of 2023. In performing this test, we incorporated information that was known through the date of filing of our Quarterly Report on Form 10-Q for the period ended September 30, 2023. We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our 2023 annual impairment test, we recognized a non-cash goodwill impairment loss of approximately $ 510 million in SG&A, which included a $ 452 million impairment loss in our Canada and North America Coffee (“CNAC”) reporting unit within our North America segment and a $ 58 million impairment loss in our Continental Europe reporting unit within our International Developed Markets segment. These impairments were primarily driven by an increase in the discount rate, which was impacted by higher interest rates, a decline in market capitalization, and other market inputs. </context> | us-gaap:GoodwillImpairmentLoss |
We performed our 2023 annual impairment test as of July 2, 2023, which was the first day of our third quarter of 2023. In performing this test, we incorporated information that was known through the date of filing of our Quarterly Report on Form 10-Q for the period ended September 30, 2023. We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our 2023 annual impairment test, we recognized a non-cash goodwill impairment loss of approximately $ 510 million in SG&A, which included a $ 452 million impairment loss in our Canada and North America Coffee (“CNAC”) reporting unit within our North America segment and a $ 58 million impairment loss in our Continental Europe reporting unit within our International Developed Markets segment. These impairments were primarily driven by an increase in the discount rate, which was impacted by higher interest rates, a decline in market capitalization, and other market inputs. | text | 58 | monetaryItemType | text: <entity> 58 </entity> <entity type> monetaryItemType </entity type> <context> We performed our 2023 annual impairment test as of July 2, 2023, which was the first day of our third quarter of 2023. In performing this test, we incorporated information that was known through the date of filing of our Quarterly Report on Form 10-Q for the period ended September 30, 2023. We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our 2023 annual impairment test, we recognized a non-cash goodwill impairment loss of approximately $ 510 million in SG&A, which included a $ 452 million impairment loss in our Canada and North America Coffee (“CNAC”) reporting unit within our North America segment and a $ 58 million impairment loss in our Continental Europe reporting unit within our International Developed Markets segment. These impairments were primarily driven by an increase in the discount rate, which was impacted by higher interest rates, a decline in market capitalization, and other market inputs. </context> | us-gaap:GoodwillImpairmentLoss |
We performed our pre-reorganization impairment test as of March 27, 2022, which was our first day of the second quarter of 2022. There were six reporting units affected by the reassignment of assets and liabilities that maintained a goodwill balance as of our pre-reorganization impairment test date. These reporting units were Enhancers, Specialty, and Away From Home (“ESA”); Kids, Snacks, and Beverages (“KSB”); Meal Foundations and Coffee (“MFC”); Puerto Rico; Canada Retail; and Canada Foodservice. One other reporting unit did not have a goodwill balance as of our pre-reorganization impairment test date. | text | six | integerItemType | text: <entity> six </entity> <entity type> integerItemType </entity type> <context> We performed our pre-reorganization impairment test as of March 27, 2022, which was our first day of the second quarter of 2022. There were six reporting units affected by the reassignment of assets and liabilities that maintained a goodwill balance as of our pre-reorganization impairment test date. These reporting units were Enhancers, Specialty, and Away From Home (“ESA”); Kids, Snacks, and Beverages (“KSB”); Meal Foundations and Coffee (“MFC”); Puerto Rico; Canada Retail; and Canada Foodservice. One other reporting unit did not have a goodwill balance as of our pre-reorganization impairment test date. </context> | us-gaap:NumberOfReportingUnits |
We performed our pre-reorganization impairment test as of March 27, 2022, which was our first day of the second quarter of 2022. There were six reporting units affected by the reassignment of assets and liabilities that maintained a goodwill balance as of our pre-reorganization impairment test date. These reporting units were Enhancers, Specialty, and Away From Home (“ESA”); Kids, Snacks, and Beverages (“KSB”); Meal Foundations and Coffee (“MFC”); Puerto Rico; Canada Retail; and Canada Foodservice. One other reporting unit did not have a goodwill balance as of our pre-reorganization impairment test date. | text | One | integerItemType | text: <entity> One </entity> <entity type> integerItemType </entity type> <context> We performed our pre-reorganization impairment test as of March 27, 2022, which was our first day of the second quarter of 2022. There were six reporting units affected by the reassignment of assets and liabilities that maintained a goodwill balance as of our pre-reorganization impairment test date. These reporting units were Enhancers, Specialty, and Away From Home (“ESA”); Kids, Snacks, and Beverages (“KSB”); Meal Foundations and Coffee (“MFC”); Puerto Rico; Canada Retail; and Canada Foodservice. One other reporting unit did not have a goodwill balance as of our pre-reorganization impairment test date. </context> | us-gaap:NumberOfReportingUnits |
As part of our pre-reorganization impairment test, we utilized the discounted cash flow method under the income approach to estimate the fair values as of March 27, 2022 for the six reporting units noted above. As a result of our pre-reorganization impairment test, we recognized a non-cash impairment loss of approximately $ 235 million in SG&A in our North America segment in the second quarter of 2022. This included a $ 221 million impairment loss related to our Canada Retail reporting unit, and a $ 14 million impairment loss related to our Puerto Rico reporting unit. The impairment of our Canada Retail reporting unit was primarily driven by an increase in the discount rate, which was impacted by higher interest rates and other market inputs, as well as a revised downward outlook for operating margin. The impairment of our Puerto Rico reporting unit was primarily driven by a revised downward outlook for operating margin. The remaining reporting units tested as part of our pre-reorganization impairment test each had excess fair value over carrying amount as of March 27, 2022. | text | six | integerItemType | text: <entity> six </entity> <entity type> integerItemType </entity type> <context> As part of our pre-reorganization impairment test, we utilized the discounted cash flow method under the income approach to estimate the fair values as of March 27, 2022 for the six reporting units noted above. As a result of our pre-reorganization impairment test, we recognized a non-cash impairment loss of approximately $ 235 million in SG&A in our North America segment in the second quarter of 2022. This included a $ 221 million impairment loss related to our Canada Retail reporting unit, and a $ 14 million impairment loss related to our Puerto Rico reporting unit. The impairment of our Canada Retail reporting unit was primarily driven by an increase in the discount rate, which was impacted by higher interest rates and other market inputs, as well as a revised downward outlook for operating margin. The impairment of our Puerto Rico reporting unit was primarily driven by a revised downward outlook for operating margin. The remaining reporting units tested as part of our pre-reorganization impairment test each had excess fair value over carrying amount as of March 27, 2022. </context> | us-gaap:NumberOfReportingUnits |
As part of our pre-reorganization impairment test, we utilized the discounted cash flow method under the income approach to estimate the fair values as of March 27, 2022 for the six reporting units noted above. As a result of our pre-reorganization impairment test, we recognized a non-cash impairment loss of approximately $ 235 million in SG&A in our North America segment in the second quarter of 2022. This included a $ 221 million impairment loss related to our Canada Retail reporting unit, and a $ 14 million impairment loss related to our Puerto Rico reporting unit. The impairment of our Canada Retail reporting unit was primarily driven by an increase in the discount rate, which was impacted by higher interest rates and other market inputs, as well as a revised downward outlook for operating margin. The impairment of our Puerto Rico reporting unit was primarily driven by a revised downward outlook for operating margin. The remaining reporting units tested as part of our pre-reorganization impairment test each had excess fair value over carrying amount as of March 27, 2022. | text | 221 | monetaryItemType | text: <entity> 221 </entity> <entity type> monetaryItemType </entity type> <context> As part of our pre-reorganization impairment test, we utilized the discounted cash flow method under the income approach to estimate the fair values as of March 27, 2022 for the six reporting units noted above. As a result of our pre-reorganization impairment test, we recognized a non-cash impairment loss of approximately $ 235 million in SG&A in our North America segment in the second quarter of 2022. This included a $ 221 million impairment loss related to our Canada Retail reporting unit, and a $ 14 million impairment loss related to our Puerto Rico reporting unit. The impairment of our Canada Retail reporting unit was primarily driven by an increase in the discount rate, which was impacted by higher interest rates and other market inputs, as well as a revised downward outlook for operating margin. The impairment of our Puerto Rico reporting unit was primarily driven by a revised downward outlook for operating margin. The remaining reporting units tested as part of our pre-reorganization impairment test each had excess fair value over carrying amount as of March 27, 2022. </context> | us-gaap:GoodwillImpairmentLoss |
As part of our pre-reorganization impairment test, we utilized the discounted cash flow method under the income approach to estimate the fair values as of March 27, 2022 for the six reporting units noted above. As a result of our pre-reorganization impairment test, we recognized a non-cash impairment loss of approximately $ 235 million in SG&A in our North America segment in the second quarter of 2022. This included a $ 221 million impairment loss related to our Canada Retail reporting unit, and a $ 14 million impairment loss related to our Puerto Rico reporting unit. The impairment of our Canada Retail reporting unit was primarily driven by an increase in the discount rate, which was impacted by higher interest rates and other market inputs, as well as a revised downward outlook for operating margin. The impairment of our Puerto Rico reporting unit was primarily driven by a revised downward outlook for operating margin. The remaining reporting units tested as part of our pre-reorganization impairment test each had excess fair value over carrying amount as of March 27, 2022. | text | 14 | monetaryItemType | text: <entity> 14 </entity> <entity type> monetaryItemType </entity type> <context> As part of our pre-reorganization impairment test, we utilized the discounted cash flow method under the income approach to estimate the fair values as of March 27, 2022 for the six reporting units noted above. As a result of our pre-reorganization impairment test, we recognized a non-cash impairment loss of approximately $ 235 million in SG&A in our North America segment in the second quarter of 2022. This included a $ 221 million impairment loss related to our Canada Retail reporting unit, and a $ 14 million impairment loss related to our Puerto Rico reporting unit. The impairment of our Canada Retail reporting unit was primarily driven by an increase in the discount rate, which was impacted by higher interest rates and other market inputs, as well as a revised downward outlook for operating margin. The impairment of our Puerto Rico reporting unit was primarily driven by a revised downward outlook for operating margin. The remaining reporting units tested as part of our pre-reorganization impairment test each had excess fair value over carrying amount as of March 27, 2022. </context> | us-gaap:GoodwillImpairmentLoss |
We performed our Q3 2022 Annual Impairment Test as of June 26, 2022, which was the first day of our third quarter of 2022. In performing this test, we incorporated information that was known through the date of filing of our Quarterly Report on Form 10-Q for the period ended September 24, 2022. We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our Q3 2022 Annual Impairment Test, we recognized a non-cash impairment loss of approximately $ 220 million in SG&A in our North America segment related to our CNAC reporting unit. The impairment of our CNAC reporting unit was primarily driven by reduced revenue growth assumptions and negative macroeconomic factors, including increased interest rates and foreign currency exchange rates for the Canadian dollar relative to the U.S. dollar. | text | 220 | monetaryItemType | text: <entity> 220 </entity> <entity type> monetaryItemType </entity type> <context> We performed our Q3 2022 Annual Impairment Test as of June 26, 2022, which was the first day of our third quarter of 2022. In performing this test, we incorporated information that was known through the date of filing of our Quarterly Report on Form 10-Q for the period ended September 24, 2022. We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our Q3 2022 Annual Impairment Test, we recognized a non-cash impairment loss of approximately $ 220 million in SG&A in our North America segment related to our CNAC reporting unit. The impairment of our CNAC reporting unit was primarily driven by reduced revenue growth assumptions and negative macroeconomic factors, including increased interest rates and foreign currency exchange rates for the Canadian dollar relative to the U.S. dollar. </context> | us-gaap:GoodwillImpairmentLoss |
Our reporting units that were impaired in 2024, 2023, and 2022 were written down to their respective fair values resulting in zero excess fair value over carrying amount as of the applicable impairment test dates. Accordingly, our reporting units that had 20 % or less excess fair value over carrying amount as of our 2024 annual impairment test have a heightened risk of future impairments if any assumptions, estimates, or market factors change in the future. Although the remaining reporting units had more than 20 % excess fair value over carrying amount as of our 2024 annual impairment test, this amount is also susceptible to impairments if any assumptions, estimates, or market factors significantly change in the future. | text | 20 | percentItemType | text: <entity> 20 </entity> <entity type> percentItemType </entity type> <context> Our reporting units that were impaired in 2024, 2023, and 2022 were written down to their respective fair values resulting in zero excess fair value over carrying amount as of the applicable impairment test dates. Accordingly, our reporting units that had 20 % or less excess fair value over carrying amount as of our 2024 annual impairment test have a heightened risk of future impairments if any assumptions, estimates, or market factors change in the future. Although the remaining reporting units had more than 20 % excess fair value over carrying amount as of our 2024 annual impairment test, this amount is also susceptible to impairments if any assumptions, estimates, or market factors significantly change in the future. </context> | us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount |
Our indefinite-lived intangible asset balance primarily consists of a number of individual brands, which had an aggregate carrying amount of $ 36.5 billion at December 28, 2024. | text | 36.5 | monetaryItemType | text: <entity> 36.5 </entity> <entity type> monetaryItemType </entity type> <context> Our indefinite-lived intangible asset balance primarily consists of a number of individual brands, which had an aggregate carrying amount of $ 36.5 billion at December 28, 2024. </context> | us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill |
As a result of our 2024 annual impairment test as of June 30, 2024, we recognized non-cash intangible asset impairment losses of $ 593 million in SG&A in the third quarter of 2024 related to our | text | 593 | monetaryItemType | text: <entity> 593 </entity> <entity type> monetaryItemType </entity type> <context> As a result of our 2024 annual impairment test as of June 30, 2024, we recognized non-cash intangible asset impairment losses of $ 593 million in SG&A in the third quarter of 2024 related to our </context> | us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill |
brands. We utilized the relief from royalty method under the income approach to estimate the fair values and recorded non-cash impairment losses of $ 560 million in our North America segment and $ 33 million in our International Developed Markets segment, consistent with ownership of the trademarks. The impairments of the | text | 560 | monetaryItemType | text: <entity> 560 </entity> <entity type> monetaryItemType </entity type> <context> brands. We utilized the relief from royalty method under the income approach to estimate the fair values and recorded non-cash impairment losses of $ 560 million in our North America segment and $ 33 million in our International Developed Markets segment, consistent with ownership of the trademarks. The impairments of the </context> | us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill |
brands. We utilized the relief from royalty method under the income approach to estimate the fair values and recorded non-cash impairment losses of $ 560 million in our North America segment and $ 33 million in our International Developed Markets segment, consistent with ownership of the trademarks. The impairments of the | text | 33 | monetaryItemType | text: <entity> 33 </entity> <entity type> monetaryItemType </entity type> <context> brands. We utilized the relief from royalty method under the income approach to estimate the fair values and recorded non-cash impairment losses of $ 560 million in our North America segment and $ 33 million in our International Developed Markets segment, consistent with ownership of the trademarks. The impairments of the </context> | us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill |
brand was primarily due to a reduction of future year margin assumptions from prior estimates. After these impairments, the aggregate carrying amount of these brands was $ 1.2 billion. | text | 1.2 | monetaryItemType | text: <entity> 1.2 </entity> <entity type> monetaryItemType </entity type> <context> brand was primarily due to a reduction of future year margin assumptions from prior estimates. After these impairments, the aggregate carrying amount of these brands was $ 1.2 billion. </context> | us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill |
During the fourth quarter of 2024, we recognized a non-cash intangible asset impairment loss of $ 1.3 billion in SG&A related to our | text | 1.3 | monetaryItemType | text: <entity> 1.3 </entity> <entity type> monetaryItemType </entity type> <context> During the fourth quarter of 2024, we recognized a non-cash intangible asset impairment loss of $ 1.3 billion in SG&A related to our </context> | us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill |
Brands with 20 % or less fair value over carrying amount had an aggregate carrying amount after impairment of $ 16.8 billion as of the latest test for each brand, brands with 20 - 50 % fair value over carrying amount had an aggregate carrying amount of $ 2.8 billion as of the latest test for each brand, and brands that had over 50 % fair value over carrying amount had an aggregate carrying amount of $ 16.9 billion as of the latest test for each brand. | text | 20 | percentItemType | text: <entity> 20 </entity> <entity type> percentItemType </entity type> <context> Brands with 20 % or less fair value over carrying amount had an aggregate carrying amount after impairment of $ 16.8 billion as of the latest test for each brand, brands with 20 - 50 % fair value over carrying amount had an aggregate carrying amount of $ 2.8 billion as of the latest test for each brand, and brands that had over 50 % fair value over carrying amount had an aggregate carrying amount of $ 16.9 billion as of the latest test for each brand. </context> | us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount |
Brands with 20 % or less fair value over carrying amount had an aggregate carrying amount after impairment of $ 16.8 billion as of the latest test for each brand, brands with 20 - 50 % fair value over carrying amount had an aggregate carrying amount of $ 2.8 billion as of the latest test for each brand, and brands that had over 50 % fair value over carrying amount had an aggregate carrying amount of $ 16.9 billion as of the latest test for each brand. | text | 16.8 | monetaryItemType | text: <entity> 16.8 </entity> <entity type> monetaryItemType </entity type> <context> Brands with 20 % or less fair value over carrying amount had an aggregate carrying amount after impairment of $ 16.8 billion as of the latest test for each brand, brands with 20 - 50 % fair value over carrying amount had an aggregate carrying amount of $ 2.8 billion as of the latest test for each brand, and brands that had over 50 % fair value over carrying amount had an aggregate carrying amount of $ 16.9 billion as of the latest test for each brand. </context> | us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill |
Brands with 20 % or less fair value over carrying amount had an aggregate carrying amount after impairment of $ 16.8 billion as of the latest test for each brand, brands with 20 - 50 % fair value over carrying amount had an aggregate carrying amount of $ 2.8 billion as of the latest test for each brand, and brands that had over 50 % fair value over carrying amount had an aggregate carrying amount of $ 16.9 billion as of the latest test for each brand. | text | 50 | percentItemType | text: <entity> 50 </entity> <entity type> percentItemType </entity type> <context> Brands with 20 % or less fair value over carrying amount had an aggregate carrying amount after impairment of $ 16.8 billion as of the latest test for each brand, brands with 20 - 50 % fair value over carrying amount had an aggregate carrying amount of $ 2.8 billion as of the latest test for each brand, and brands that had over 50 % fair value over carrying amount had an aggregate carrying amount of $ 16.9 billion as of the latest test for each brand. </context> | us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount |
Brands with 20 % or less fair value over carrying amount had an aggregate carrying amount after impairment of $ 16.8 billion as of the latest test for each brand, brands with 20 - 50 % fair value over carrying amount had an aggregate carrying amount of $ 2.8 billion as of the latest test for each brand, and brands that had over 50 % fair value over carrying amount had an aggregate carrying amount of $ 16.9 billion as of the latest test for each brand. | text | 2.8 | monetaryItemType | text: <entity> 2.8 </entity> <entity type> monetaryItemType </entity type> <context> Brands with 20 % or less fair value over carrying amount had an aggregate carrying amount after impairment of $ 16.8 billion as of the latest test for each brand, brands with 20 - 50 % fair value over carrying amount had an aggregate carrying amount of $ 2.8 billion as of the latest test for each brand, and brands that had over 50 % fair value over carrying amount had an aggregate carrying amount of $ 16.9 billion as of the latest test for each brand. </context> | us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill |
Brands with 20 % or less fair value over carrying amount had an aggregate carrying amount after impairment of $ 16.8 billion as of the latest test for each brand, brands with 20 - 50 % fair value over carrying amount had an aggregate carrying amount of $ 2.8 billion as of the latest test for each brand, and brands that had over 50 % fair value over carrying amount had an aggregate carrying amount of $ 16.9 billion as of the latest test for each brand. | text | 16.9 | monetaryItemType | text: <entity> 16.9 </entity> <entity type> monetaryItemType </entity type> <context> Brands with 20 % or less fair value over carrying amount had an aggregate carrying amount after impairment of $ 16.8 billion as of the latest test for each brand, brands with 20 - 50 % fair value over carrying amount had an aggregate carrying amount of $ 2.8 billion as of the latest test for each brand, and brands that had over 50 % fair value over carrying amount had an aggregate carrying amount of $ 16.9 billion as of the latest test for each brand. </context> | us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill |
As a result of our 2023 annual impairment test as of July 2, 2023, we recognized non-cash intangible asset impairment losses of $ 152 million in SG&A in the third quarter of 2023 related to | text | 152 | monetaryItemType | text: <entity> 152 </entity> <entity type> monetaryItemType </entity type> <context> As a result of our 2023 annual impairment test as of July 2, 2023, we recognized non-cash intangible asset impairment losses of $ 152 million in SG&A in the third quarter of 2023 related to </context> | us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill |
and two other brands. We utilized the relief from royalty method under the income approach to estimate the fair values and recorded non-cash impairment losses of $ 139 million in our North America segment and $ 13 million in our International Developed Markets segment, consistent with ownership of the trademarks. The impairment of these four brands was primarily due to an increase in the discount rate, which was impacted by higher interest rates, a decline in market capitalization, and other market inputs, as well as sustained expectations of declining revenue growth in future years, and decreased margin expectations. | text | 139 | monetaryItemType | text: <entity> 139 </entity> <entity type> monetaryItemType </entity type> <context> and two other brands. We utilized the relief from royalty method under the income approach to estimate the fair values and recorded non-cash impairment losses of $ 139 million in our North America segment and $ 13 million in our International Developed Markets segment, consistent with ownership of the trademarks. The impairment of these four brands was primarily due to an increase in the discount rate, which was impacted by higher interest rates, a decline in market capitalization, and other market inputs, as well as sustained expectations of declining revenue growth in future years, and decreased margin expectations. </context> | us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill |
and two other brands. We utilized the relief from royalty method under the income approach to estimate the fair values and recorded non-cash impairment losses of $ 139 million in our North America segment and $ 13 million in our International Developed Markets segment, consistent with ownership of the trademarks. The impairment of these four brands was primarily due to an increase in the discount rate, which was impacted by higher interest rates, a decline in market capitalization, and other market inputs, as well as sustained expectations of declining revenue growth in future years, and decreased margin expectations. | text | 13 | monetaryItemType | text: <entity> 13 </entity> <entity type> monetaryItemType </entity type> <context> and two other brands. We utilized the relief from royalty method under the income approach to estimate the fair values and recorded non-cash impairment losses of $ 139 million in our North America segment and $ 13 million in our International Developed Markets segment, consistent with ownership of the trademarks. The impairment of these four brands was primarily due to an increase in the discount rate, which was impacted by higher interest rates, a decline in market capitalization, and other market inputs, as well as sustained expectations of declining revenue growth in future years, and decreased margin expectations. </context> | us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill |
We performed our Q3 2022 Annual Impairment Test as of June 26, 2022, which was our first day of the third quarter of 2022. As a result of our Q3 2022 Annual Impairment Test we recognized a non-cash impairment loss of $ 67 million in SG&A in the third quarter of 2022 related to two brands, | text | 67 | monetaryItemType | text: <entity> 67 </entity> <entity type> monetaryItemType </entity type> <context> We performed our Q3 2022 Annual Impairment Test as of June 26, 2022, which was our first day of the third quarter of 2022. As a result of our Q3 2022 Annual Impairment Test we recognized a non-cash impairment loss of $ 67 million in SG&A in the third quarter of 2022 related to two brands, </context> | us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill |
. We utilized the relief from royalty method under the income approach to estimate the fair values and recorded non-cash impairment losses of $ 50 million in our North America segment and $ 17 million in our International Developed Markets segment, consistent with ownership of the trademarks. The impairment of these brands was primarily due to reduced revenue growth assumptions. | text | 50 | monetaryItemType | text: <entity> 50 </entity> <entity type> monetaryItemType </entity type> <context> . We utilized the relief from royalty method under the income approach to estimate the fair values and recorded non-cash impairment losses of $ 50 million in our North America segment and $ 17 million in our International Developed Markets segment, consistent with ownership of the trademarks. The impairment of these brands was primarily due to reduced revenue growth assumptions. </context> | us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill |
. We utilized the relief from royalty method under the income approach to estimate the fair values and recorded non-cash impairment losses of $ 50 million in our North America segment and $ 17 million in our International Developed Markets segment, consistent with ownership of the trademarks. The impairment of these brands was primarily due to reduced revenue growth assumptions. | text | 17 | monetaryItemType | text: <entity> 17 </entity> <entity type> monetaryItemType </entity type> <context> . We utilized the relief from royalty method under the income approach to estimate the fair values and recorded non-cash impairment losses of $ 50 million in our North America segment and $ 17 million in our International Developed Markets segment, consistent with ownership of the trademarks. The impairment of these brands was primarily due to reduced revenue growth assumptions. </context> | us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill |
licensed products (the “TGI Friday License”). The total cash consideration related to the TGI Friday License was approximately $ 140 million. We recognized this TGI Friday License as a definite-lived intangible asset to be amortized over its 27-year useful life. | text | 140 | monetaryItemType | text: <entity> 140 </entity> <entity type> monetaryItemType </entity type> <context> licensed products (the “TGI Friday License”). The total cash consideration related to the TGI Friday License was approximately $ 140 million. We recognized this TGI Friday License as a definite-lived intangible asset to be amortized over its 27-year useful life. </context> | us-gaap:FiniteLivedLicenseAgreementsGross |
In the third quarter of 2024, we recognized non-cash definite-lived intangible asset impairment losses of $ 128 million in SG&A related to the | text | 128 | monetaryItemType | text: <entity> 128 </entity> <entity type> monetaryItemType </entity type> <context> In the third quarter of 2024, we recognized non-cash definite-lived intangible asset impairment losses of $ 128 million in SG&A related to the </context> | us-gaap:ImpairmentOfIntangibleAssetsFinitelived |
Amortization expense for definite-lived intangible assets was $ 252 million in 2024, $ 251 million in 2023, and $ 261 million in 2022. Aside from amortization expense, the change in definite-lived intangible assets from December 30, 2023 to December 28, 2024 primarily relates to the acquisition of the TGI Friday License, the $ 128 million of non-cash impairment losses related to the | text | 252 | monetaryItemType | text: <entity> 252 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense for definite-lived intangible assets was $ 252 million in 2024, $ 251 million in 2023, and $ 261 million in 2022. Aside from amortization expense, the change in definite-lived intangible assets from December 30, 2023 to December 28, 2024 primarily relates to the acquisition of the TGI Friday License, the $ 128 million of non-cash impairment losses related to the </context> | us-gaap:AmortizationOfIntangibleAssets |
Amortization expense for definite-lived intangible assets was $ 252 million in 2024, $ 251 million in 2023, and $ 261 million in 2022. Aside from amortization expense, the change in definite-lived intangible assets from December 30, 2023 to December 28, 2024 primarily relates to the acquisition of the TGI Friday License, the $ 128 million of non-cash impairment losses related to the | text | 251 | monetaryItemType | text: <entity> 251 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense for definite-lived intangible assets was $ 252 million in 2024, $ 251 million in 2023, and $ 261 million in 2022. Aside from amortization expense, the change in definite-lived intangible assets from December 30, 2023 to December 28, 2024 primarily relates to the acquisition of the TGI Friday License, the $ 128 million of non-cash impairment losses related to the </context> | us-gaap:AmortizationOfIntangibleAssets |
Amortization expense for definite-lived intangible assets was $ 252 million in 2024, $ 251 million in 2023, and $ 261 million in 2022. Aside from amortization expense, the change in definite-lived intangible assets from December 30, 2023 to December 28, 2024 primarily relates to the acquisition of the TGI Friday License, the $ 128 million of non-cash impairment losses related to the | text | 261 | monetaryItemType | text: <entity> 261 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense for definite-lived intangible assets was $ 252 million in 2024, $ 251 million in 2023, and $ 261 million in 2022. Aside from amortization expense, the change in definite-lived intangible assets from December 30, 2023 to December 28, 2024 primarily relates to the acquisition of the TGI Friday License, the $ 128 million of non-cash impairment losses related to the </context> | us-gaap:AmortizationOfIntangibleAssets |
Amortization expense for definite-lived intangible assets was $ 252 million in 2024, $ 251 million in 2023, and $ 261 million in 2022. Aside from amortization expense, the change in definite-lived intangible assets from December 30, 2023 to December 28, 2024 primarily relates to the acquisition of the TGI Friday License, the $ 128 million of non-cash impairment losses related to the | text | 128 | monetaryItemType | text: <entity> 128 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense for definite-lived intangible assets was $ 252 million in 2024, $ 251 million in 2023, and $ 261 million in 2022. Aside from amortization expense, the change in definite-lived intangible assets from December 30, 2023 to December 28, 2024 primarily relates to the acquisition of the TGI Friday License, the $ 128 million of non-cash impairment losses related to the </context> | us-gaap:ImpairmentOfIntangibleAssetsFinitelived |
In the third quarter of 2022, we recorded $ 7 million of non-cash intangible asset impairment losses to SG&A related to two trademarks in our former International segment that had net carrying values that were deemed not to be recoverable. | text | 7 | monetaryItemType | text: <entity> 7 </entity> <entity type> monetaryItemType </entity type> <context> In the third quarter of 2022, we recorded $ 7 million of non-cash intangible asset impairment losses to SG&A related to two trademarks in our former International segment that had net carrying values that were deemed not to be recoverable. </context> | us-gaap:ImpairmentOfIntangibleAssetsFinitelived |
End of preview. Expand
in Data Studio
README.md exists but content is empty.
- Downloads last month
- 10
Size of downloaded dataset files:
3.99 MB
Size of the auto-converted Parquet files:
3.99 MB
Number of rows:
52,572